Cargando…

Pretreatment Fibrinogen-Albumin Ratio (FAR) Associated with Treatment Response and Survival in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Anti-PD-1 Therapy Plus Platinum-Based Combination Chemotherapy

PURPOSE: PD-1 inhibitors have been routinely used to treat advanced non-small cell lung cancer (NSCLC) and have significantly improved clinical outcomes. In this study, we aimed to explore the influence of pretreatment fibrinogen-albumin ratio (FAR) on treatment response and survival in advanced NSC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yuan, Chengliang, Huang, Meifang, Wang, Huilin, Jiang, Wei, Su, Cuiyun, Zhou, Shaozhang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801367/ https://www.ncbi.nlm.nih.gov/pubmed/35115834 http://dx.doi.org/10.2147/CMAR.S347547

Ejemplares similares

The prognostic value of pretreatment albumin-to-fibrinogen ratio in small cell lung cancer patients receiving first-line platinum-based chemotherapy
por: Li, Qi, et al.
Publicado: (2023)

Preoperative Neutrophil-Lymphocyte Ratio (NLR)-Binding Fibrinogen-Albumin Ratio (FAR) Is Superior to Platelet-Lymphocyte Ratio (PLR)-Binding Fibrinogen-Albumin Ratio (FAR) and Lymphocyte-Monocyte (LMR)-Binding Fibrinogen-Albumin Ratio (FAR) as Predictors of Survival in Surgical Patients with Colorectal Adenocarcinoma
por: Zhao, Xin, et al.
Publicado: (2023)

Pretreatment albumin/fibrinogen ratio as a promising predictor for the survival of advanced non small-cell lung cancer patients undergoing first-line platinum-based chemotherapy
por: Ying, Jun, et al.
Publicado: (2019)

The potential value of fibrinogen to albumin ratio (FAR) in the assessment of inflammation in spondyloarthritis
por: Ding, Yimei, et al.
Publicado: (2022)

PD-1/PD-L1 inhibitors plus anti-angiogenic agents with or without chemotherapy versus PD-1/PD-L1 inhibitors plus chemotherapy as second or later-line treatment for patients with advanced non-small cell lung cancer: A real-world retrospective cohort study
por: Chen, Shubin, et al.
Publicado: (2022)

Predictive value of pretreatment albumin‐to‐alkaline phosphatase ratio for overall survival for patients with advanced non‐small cell lung cancer
por: Zhou, Shaozhang, et al.
Publicado: (2020)

Prognostic value of the fibrinogen/albumin ratio (FAR) in patients with operable soft tissue sarcoma
por: Liang, Yao, et al.
Publicado: (2018)

Prognostic value of fibrinogen-to-albumin ratio in patients with gastric cancer receiving first-line chemotherapy
por: Zhang, Liqun, et al.
Publicado: (2020)

Comparison of Different EGFR Gene Mutation Status in Patients with Metastatic Non-Small Lung Cancer After First-Line EGFR-TKIs Therapy and Analyzing Its Relationship with Efficacy and Prognosis
por: Yuan, Chengliang, et al.
Publicado: (2021)

Fibrinogen–Albumin Ratio Index (FARI) as a Certain Prognostic Biomarker in Pretreated Patients with Immunotherapy
por: Guo, Ziwei, et al.
Publicado: (2021)

Fibrinogen-to-Albumin Ratio in Neonatal Sepsis
por: Dong, Geng, et al.
Publicado: (2023)

Influence of Fibrinogen/Albumin Ratio and Fibrinogen/Pre-Albumin Ratio on Cardiac Autonomic Neuropathy in Type 2 Diabetes
por: Zhao, Subei, et al.
Publicado: (2023)

Fibrinogen/albumin ratio as a promising predictor of platinum response and survival in ovarian clear cell carcinoma
por: Chen, Wei, et al.
Publicado: (2022)

Elevated Pretreatment Fibrinogen-to-Lymphocyte Percentage Ratio Predict Tumor Staging and Poor Survival in Non-Small Cell Lung Cancer Patients with Chemotherapy or Surgery Combined with Chemotherapy
por: Liu, Meifang, et al.
Publicado: (2021)

Fibrinogen–Albumin Ratio Index Exhibits Predictive Value of Neoadjuvant Chemotherapy in Osteosarcoma
por: Li, Zhendong, et al.
Publicado: (2022)

Role of fibrinogen, albumin and fibrinogen to albumin ratio in determining angiographic severity and outcomes in acute coronary syndrome
por: Makkar, Kunaal, et al.
Publicado: (2023)

Albumin-fibrinogen ratio and fibrinogen-prealbumin ratio as promising prognostic markers for cancers: an updated meta-analysis
por: Sun, Da-wei, et al.
Publicado: (2020)

Prognostic Value of Pretreatment Albumin-to-Alkaline Phosphatase Ratio in Extensive-Disease Small-Cell Lung Cancer: A Retrospective Cohort Study
por: Zhou, Shaozhang, et al.
Publicado: (2020)

Control of Fibrinogen Biosynthesis: Role of the FFA/Albumin Ratio
por: Pilgeram, Laurence
Publicado: (2010)

Fibrinogen/Albumin Ratio (FAR) in Patients with Triple Negative Breast Cancer and Its Relationship with Epidermal Growth Factor Receptor Expression
por: Gao, Wenbo, et al.
Publicado: (2021)

Predictive impact of fibrinogen-to-albumin ratio (FAR) for left ventricular dysfunction in acute coronary syndrome: a cross-sectional study
por: Wang, Xuan, et al.
Publicado: (2023)

Pretreatment Albumin-to-Fibrinogen Ratio Independently Predicts Chemotherapy Response and Prognosis in Patients with Locally Advanced Rectal Cancer Undergoing Total Mesorectal Excision After Neoadjuvant Chemoradiotherapy
por: Li, Hongzhi, et al.
Publicado: (2020)

Preoperative albumin-to-fibrinogen ratio predicts chemotherapy resistance and prognosis in patients with advanced epithelial ovarian cancer
por: Yu, Wen, et al.
Publicado: (2019)

The value of circulating fibrinogen-to-pre-albumin ratio in predicting survival and benefit from chemotherapy in colorectal cancer
por: Ying, Hou-Qun, et al.
Publicado: (2021)

The association between fibrinogen-to-albumin ratio (FAR) and adverse prognosis in patients with acute decompensated heart failure at different glucose metabolic states
por: Huang, Rong, et al.
Publicado: (2022)

Prognostic significance of the fibrinogen-to-albumin ratio in gallbladder cancer patients
por: Xu, Wei-Yu, et al.
Publicado: (2018)

Prognostic Influence of Preoperative Fibrinogen to Albumin Ratio for Breast Cancer
por: Hwang, Ki-Tae, et al.
Publicado: (2017)

Prognostic value of albumin-fibrinogen ratio in subarachnoid hemorrhage patients
por: Liu, Xuyang, et al.
Publicado: (2021)

Prognostic Significance of the Albumin to Fibrinogen Ratio in Peritoneal Dialysis Patients
por: Xia, Wenkai, et al.
Publicado: (2022)

Fibrinogen-to-albumin ratio predicts overall survival of hepatocellular carcinoma
por: Sun, Hao, et al.
Publicado: (2023)

The Effect of PD-1 Inhibitor Combined with Chemotherapy on the Level of Peripheral Blood T Lymphocytes among Patients with Non-Small-Cell Lung Cancer and Its Relationship with Prognosis
por: Zhao, Yun, et al.
Publicado: (2022)

Novel prognostic score based on the preoperative total bilirubin-albumin ratio and fibrinogen-albumin ratio in ampullary adenocarcinoma
por: Zhang, Xiao-Jie, et al.
Publicado: (2023)

Phase I/II study of oral etoposide plus GM-CSF as second-line chemotherapy in platinum-pretreated patients with advanced ovarian cancer
por: Baur, M, et al.
Publicado: (2005)

Albumin and the fibrinogen-to-albumin ratio: Biomarkers for the acute phase response following total knee arthroplasty
por: Amaro, Emilie, et al.
Publicado: (2021)

Does the fibrinogen/albumin ratio predict the prognosis of pregnancies with abortus imminens?
por: Usta, Ceyda S., et al.
Publicado: (2021)

Fibrinogen-to-Albumin Ratio is Associated with All-Cause Mortality in Cancer Patients
por: Wen, Yanling, et al.
Publicado: (2021)

Prognostic Value of Preoperative Albumin-to-Fibrinogen Ratio in Patients with Bladder Cancer
por: Li, Shuai, et al.
Publicado: (2021)

Data of postoperative complications related to fibrinogen-to-albumin ratio in pancreatic resections()
por: La Vaccara, V., et al.
Publicado: (2022)

Prognostic value of albumin to fibrinogen ratio for mortality in patients with hypertrophic cardiomyopathy
por: Li, Liying, et al.
Publicado: (2023)

Prognostic Value of Fibrinogen-to-Albumin Ratio in Coronary Three-Vessel Disease
por: Li, Xinsheng, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8ebi2rfpj2cecoriv772ju5aiq